Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if AVIR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
21 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
124 filers reported a long position in AVIR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $55.8M | 12M | +0.4% |
| BlackRock, Inc. | $40.5M | 8.7M | +3.4% |
| BML Capital Management, LLC | $32.3M | 7M | -1.5% |
| TANG CAPITAL MANAGEMENT LLC | $22.4M | 4.8M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.8M | 3M | -8.7% |
| Bain Capital Life Sciences Investors, LLC | $9.7M | 2.1M | -12.1% |
| ACADIAN ASSET MANAGEMENT LLC | $9.5M | 2M | +28.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $9.1M | 2M | +12.1% |
| STATE STREET CORP | $7.7M | 1.7M | -2.5% |
| TWO SIGMA INVESTMENTS, LP | $7M | 1.5M | -19.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.